Physician profile
Meredith Hill
NPI 1437613429
$7,472.05
in general payments reported to CMS, 2019-2025
14 companies · $4,264 in 2025
The $4,264 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $768 · 2022: $616 · 2023: $684 · 2024: $1,140 · 2025: $4,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,300 · Travel and Lodging: $1,934 · Food and Beverage: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,300.00 |
| Travel and Lodging | $1,933.74 |
| Food and Beverage | $1,854.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,076.16 | 2021-2025 | |
| Solventum Corporation | $944.73 | 2024-2025 | Prevena, Spoton, 3m Skin and Nasal Antiseptic |
| Hollister Incorporated | $879.72 | 2021-2025 | New Image, Premier, Hollister |
| Molnlycke Health Care US, LLC | $498.22 | 2022-2025 | Mepilex Border Sacrum, Mepilex Border Flex, Mlnlyckez-Flo Fluidized Positioner |
| Organogenesis INC. | $387.67 | 2022-2025 | Puraply Antimicrobial, Puraply, Apligraf |
| Coloplast Corp | $130.18 | 2024 | |
| Smith+Nephew, INC. | $129.42 | 2021-2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Novo Nordisk INC | $123.11 | 2021 | |
| Kci USA, INC. | $88.79 | 2021-2023 | V.A.C. Veraflo, Promogran Prisma, Prevena |
| Kerecis Limited | $82.08 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Avita Medical Americas, LLC | $47.65 | 2024 | |
| Urgo Medical North America, LLC | $40.31 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Hydrofera LLC | $22.05 | 2023 | Hydrofera Blue |
| Polynovo North America LLC | $21.96 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.